Oncology Pharmacy Practice Residency Post Graduate Year 2 (PGY2) - Rochester, Minn.

Program Description
Mayo School of Health Sciences (MSHS) at Mayo Clinic in Rochester, Minn., offers a one-year postgraduate PGY-2 Oncology Pharmacy Practice Residency. The program is designed for practitioners who desire advanced training in oncology pharmacotherapy.

This program provides the high-quality didactic and clinical experiences needed to create a well-rounded, fully competent oncology pharmacist. As an oncology pharmacy practice resident you will:

• Develop expertise, knowledge and skills in oncology therapeutics.
• Contribute to an interdisciplinary health-care team offering patient-specific therapeutic interventions to treat, cure, rehabilitate and alleviate medical conditions and diseases unique to cancer patients.
• Enhance your skills in conducting clinical research.
• Strengthen your communication skills by presenting formal and informal lectures, writing professional manuscripts and leading interdisciplinary discussions.

Mayo Clinic’s Oncology Pharmacy Practice Residency provides opportunities for advanced training in all areas related to cancer. During each rotation you will work closely with your primary preceptor, highly qualified pharmacists, as well as oncology physicians and other allied health professionals.

Accreditation
Mayo School of Health Sciences’ Oncology Pharmacy Practice Residency is accredited by the American Society of Health-System Pharmacists (ASHP).

Mayo Foundation is also accredited by the North Central Association of Colleges and Schools Higher Learning Commission.

Facilities
The Mayo Clinic campus in Rochester is comprised of an extensive outpatient complex, Saint Marys Hospital, Rochester Methodist Hospital, as well as multiple research and education facilities. The Mayo Clinic Cancer Center is a National Cancer Institute (NCI)-designated cancer center with a national presence.  More than 19,500 new cancer patients are treated at Mayo Clinic every year, making it one of the largest cancer treatment facilities in the nation. Hundreds of clinical trials are available for patients, led by Mayo scientists, the North Central Cancer Treatment Group or Cancer Prevention Network.  Additional trials are also available through cooperative research agreements with the NCI and other clinical trial groups.

Pharmacy Services
Mayo Clinic's Pharmacy Services employs about 500 people, including approximately 200 pharmacists. The pharmacies operate 24 hours per day and provide pharmaceutical services, including:

• Central pharmacy distribution
• Sterile and non-sterile compounding
• Computerized intravenous admixture and unit dose dispensing
• Advanced technology support, including wireless PC’s, automated dispensing devices and clinical decision support tools
• Investigational drug studies
• Skilled nursing facility dispensing and consulting
• Decentralized pharmacist practice
• Pharmacokinetic monitoring
• Patient education programs
• Clinical pharmacy specialty practices
• Drug information programs
• In-service education
• Pharmacy, therapeutics and formulary committee participation
• Physician newsletters
• Pharmacist-led research

Mayo Clinic uses a computer-based pharmaceutical care (P-Care) monitoring system. P-Care integrates data from disparate computer systems, including pharmacy, admissions, laboratory and microbiology. Computerized algorithms utilize this data to alert pharmacists to potential situations where therapy, safety or costs can be improved. Performing daily pharmaceutical care duties, P-Care is used to:

• Provide patient demographic data, laboratory data, microbiology data, medications, parenteral nutrition information and drug levels.
• Identify patients whose medication therapy requires a pharmacist's daily review.
• Identify and review treatments that are inconsistent with established medication rule-based algorithms.
• Document pharmacist-performed clinical activities, interventions and monitoring notes.
• Provide a forum for pharmacists, pharmacy residents and pharmacy students to communicate pertinent patient-specific, medication-related issues.

Certification
Upon successful completion of your PGY-2 Oncology Pharmacy Practice Residency, you will receive a Certificate of Completion from College of Medicine, Mayo School of Health Sciences. Graduates are eligible to take the Board of Pharmaceutical Specialities’ examinations in oncology pharmacy and/or pharmacotherapy.

Hours
For the majority of the residency, your learning schedule will include ten-hour days, five days per week. In addition, you will be scheduled every 3rd weekend to assist with provision of clinical services.

Positions
Each year, Mayo School of Health Sciences admits one resident to its Oncology Pharmacy Practice Residency at Mayo Clinic in Rochester. This ensures you will receive a comprehensive educational experience with close one-on-one instruction. There are currently a total of eight pharmacy residents at Mayo Clinic in Rochester.